Anticoagulation in COVID-19: not strong for too long? - 04/05/21
Doi : 10.1016/j.accpm.2021.100857
Charles Tacquard a, ⁎ 
, Alexandre Mansour b, Alexandre Godon c, Yves Gruel d, Sophie Susen e, Anne Godier f, Pierre Albaladejo c
, Alexandre Mansour b, Alexandre Godon c, Yves Gruel d, Sophie Susen e, Anne Godier f, Pierre Albaladejo c a Department of Anaesthesia and Intensive Care, Hôpitaux Universitaires de Strasbourg, 1, Place de l’Hôpital, 67091 Strasbourg Cedex, France
b Department of Anaesthesiology Critical Care Medicine and Perioperative Medicine, CHU de Rennes, Rennes, France
c Department of Anaesthesiology and Critical Care, Grenoble Alpes University Hospital, Grenoble, France
d Department of Haematology-Haemostasis, Tours University Hospital, France
e Heart and Lung Institute, Haemostasis Department, CHU Lille, 59037 Lille Cedex, France
f Department of Anaesthesiology and Critical Care, European Georges Pompidou Hospital, Assistance Publique-Hôpitaux de Paris, Paris University, Paris, France
⁎Corresponding author.
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Keywords : COVID-19, Thrombosis, Bleeding, Complications, Anticoagulation
Il testo completo di questo articolo è disponibile in PDF.
Mappa
© 2021
Société française d'anesthésie et de réanimation (Sfar). Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 40 - N° 2
Articolo 100857- Aprile 2021 Ritorno al numero
Articolo precedente
- Even vaccinated against COVID-19, we must continue to wear a mask
- Jean-Ralph Zahar, Bernard Allaouchiche
- Job strain and psychological impact of COVID-19 in ICU caregivers during pandemic period
- Anaëlle Caillet, Ismaël Conejero, Bernard Allaouchiche
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.